Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma

Blood

Volumn 88, Issue 5, 1996, Pages 1780-1787

  Witzig, Thomas E ^a   Gertz, Morie A ^a   Lust, John A ^a   Kyle, Robert A ^a   O'Fallon, William M ^a   Greipp, Philip R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CALCIUM ION; CREATININE;

ADULT; AGED; ARTICLE; BONE MARROW; BONE METASTASIS; BONE RADIOGRAPHY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OSTEOLYSIS; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0029814466     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1780.bloodjournal8851780     Document Type: Article

References (47)

1. Ginsberg D: Circulating plasma cells in multiple myeloma: A method for detection and review of the problem. Ann Intern Med 57:843, 1962
2. Bakkus M, Van Riet I, Van Camp B, Thielemans K: Evidence that the clonogenic cell in multiple myeloma originates from a preswitched but somatically mutated B cell. Br J Haematol 87:68, 1994
3. Berenson J, Wong R, Kim K, Brown N, Lichtenstein A: Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 70:1550, 1987
4. Biberfeld P, Mellstedt H, Pettersson D: Ultrastructural and immunochemical characterization of circulating mononuclear cells in patients with myelomatosis. Acta Pathol Microbiol Scand 85:611, 1977
5. Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken M, Van Ness B: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818, 1992
6. Boccadoro M, Gavarotti P, Fossati G, Massaia M, Pileri A, Durie B: Kinetics of circulating B-lymphocytes in human myeloma. Blood 61:812, 1983
7. Cassel A, Leibovitz N, Hornstein L, Quitt M, Aghai E: Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Exp Hematol 18:1171, 1990
8. Fend F, Weyrer K, Drach J, Schwaiger A, Umlauft F, Grünewald K: Immunoglobulin gene rearrangement in plasma cell dyscrasias: Detection of small clonal cell populations in peripheral blood and bone marrow. Leuk Lymphoma 10:223, 1993
9. + monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 78:711, 1991
10. Joshua D, Ioannidis R, Brown R, Francis S, Gibson J, Kronenberg H: Multiple myeloma: Relationship between light chain isotype suppression, labeling index of plasma cells and CD38 expression on peripheral blood lymphocytes. Am J Hematol 29:5, 1988
11. Österborg A, Steinitz M, Lewin N, Bergenbrant S, Holm G, Lefvert A-K, Mellstedt H: Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy. Blood 78:2642, 1991
12. Witzig T, Dhodapkar M, Kyle R, Greipp P: Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108, 1993
13. Morissette L, Watkins C: Multiple myeloma: Diagnostic value of the blood smear. Mayo Clin Proc 17:433, 1942
14. Omedé P, Boccadoro M, Gallone G, Frieri R, Battaglio S, Redoglia V, Pileri A: Multiple myeloma: Increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood 76:1375, 1990
15. Ruiz-Argüelles G, Katzmann J, Greipp P, Gonchoroff N, Garton J, Kyle R: Multiple myeloma: Circulating lymphocytes that express plasma cell antigens. Blood 64:352, 1984
16. Bagg A, Becker P, Bezwoda W, Van Rensburg L, Mendelow B: Circulating monotypic B-cells in multiple myeloma: Association with lambda paraproteins. Br J Haematol 72:167, 1989
17. Boccadoro M, Omedé P, Massaia M, Dianzani U, Pioppo P, Battaglio S, Meregalli M, Pileri A: Human myeloma: Several subsets of circulating lymphocytes express plasma cell-associated antigens. Eur J Haematol 40:299, 1988
18. Pettersson D, Mellstedt H, Holm G, Bjøorkholm M: Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage. Scand J Haematol 27:287, 1981
19. Büichi G, Giorotto M, Veglio M, Clerico M, Gario S, Termine G, Autino R: Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies. Haematologica 75:132, 1990
20. Chiu E, Ganeshaguru K, Hoffbrand A, Mehta A: Circulating monoclonal B lymphocytes in multiple myeloma. Br J Haematol 72:28, 1989
21. Mellstedt H, Pettersson D, Holm G: Monoclonal B-lymphocytes in peripheral blood of patients with plasma cell myeloma: Relation to activity of disease. Scand J Haematol 16:112, 1976
22. Witzig T, Gonchoroff N, Katzmann J, Therneau T, Kyle R, Greipp P: Peripheral blood B-cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J Clin Oncol 6:1041, 1988
23. Witzig T, Gertz M, Lust J, Kyle R, Greipp P: Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: When is the optimal time for stem cell harvest? Leuk Lymphoma 19:417, 1995
24. Dimopoulos M, Alexanian R, Przepiorka D, Hester J, Andersson B, Giralt S, Mehra R, van Besien K, Delasalle K, Reading C, Deisseroth A, Champlin R: Thiotepa, busulfan, and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 82:2324, 1993
25. Fermand J-P, Chevret S, Ravaud P, Divine M, Leblond V, Dreyfus F, Mariette X, Brouet J-C: High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients. Blood 82:2005, 1993
26. Jagannath S, Barlogie B, Dicke K, Alexanian R, Zagars G, Cheson B, Lemaistre F, Smallwood L, Pruitt K, Dixon D: Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors. Blood 76:1860, 1990
27. Ventura G, Barlogie B, Hester J, Yau J, LeMaistre C, Wallerstein R, Spinolo J, Dicke K, Horwitz L, Alexanian R: High dose cyclophosphamide, BCNU, and VP-16 with autologous blood stem cell support for refractory multiple myeloma. Bone Marrow Transplant 9:11, 1990
28. Gertz M, Pineda A, Chen M, Letendre L, Greipp P, Solberg L, Jr, Witzig T, Garton J, Inwards D, Litzow M, Tefferi A, Kyle R, Noel P: Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. Am J Med Sci 309:152, 1995
29. Harousseau J-L, Attal M, Divine M, Marit G, Leblond V, Stoppa A-M, Bourhis J-H, Caillot D, Boasson M, Abgrall J-F, Facon T, Linassier C, Cahn J-Y, Lamy T, Troussard X, Gratecos N, Pignon B, Auzanneau G, Bataille R: Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French registry on autologous transplantation in multiple myeloma. Blood 85:3077, 1995
30. Witzig T, Gertz M, Pineda A, Kyle R, Greipp P: Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. Br J Haematol 89:640, 1995
31. Vora A, Toh C, Peel J, Greaves M: Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: Risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration. Br J Haematol 86:180, 1994
32. Mariette X, Fermand J-P, Brouet J-C: Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplant 14:47, 1994
33. Greipp P, Lust J, O'Fallon M, Katzmann J, Witzig T, Kyle R: Plasma cell labeling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 81:3382, 1993
34. Witzig T, Kyle R, O'Fallon W, Greipp P: Detection of peripheral blood plasma cells as a predictor of disease course in patients with smoldering multiple myeloma. Br J Haematol 87:266, 1994
35. Witzig T, Gonchoroff N, Ahmann G, Katzmann J, Greipp P: T-cell depletion using anti-CD2 coated magnetic beads simplifies the detection of peripheral blood plasma cells. J Immunol Methods 144:253, 1991
36. Witzig T, Kimlinger T, Ahmann G, Katzmann J, Greipp P: Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 26:113, 1996
37. Billadeau D, Van Ness B, Kimlinger T, Kyle R, Themeau T, Greipp P, Witzig T: Clonal circulating cells are common in plasma cell proliferative disorders: A comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood 88:289, 1996
38. Greipp P, Witzig T, Gonchoroff N: Immunofluorescent plasma cell labeling indices using a monoclonal antibody (BU-1), Am J Hematol 20:289, 1985
39. Greipp P, Raymond N, Kyle R, O'Fallon W: Multiple myeloma: Significance of plasmablastic subtype in morphological classification. Blood 65:305, 1985
40. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
41. Efron B: The Jacknife, the Bootstrap, and Other Resampling Plans. Philadelphia, PA, Society for Industrial and Applied Mathematics (SIAM) CBMS-NSF Monograph 38, 1982
42. Bataille R, Boccadoro M, Klein B, Durie B, Pileri A: C-reactive protein and β-2 microglobulin produce a simple and powerful myeloma staging system. Blood 80:733, 1992
43. Greipp P, Kyle R: Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood 62:166, 1983
44. Noel P, Kyle R: Plasma cell leukemia: An evaluation of response to therapy. Am J Med 83:1062, 1987
45. Kyle R: Multiple myeloma: Review of 869 cases. Mayo Clin Proc 50:29, 1975
46. Gertz M, Witzig T, Pineda A, Greipp P, Kyle R, Litzow M: Monoclonal plasma cells in the peripheral blood stem cell harvest of patients with multiple myeloma is associated with shortened relapse-free survival following transplantation. Blood 86:207a, 1995 (suppl 1)
47. Kyle R: Why better prognostic factors for multiple myeloma are needed. Blood 83:1713, 1994